Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Establishment Labs Holdings Inc before investing.

In this article, we go over a few key elements for understanding Establishment Labs Holdings Inc’s stock price such as:

• Establishment Labs Holdings Inc’s current stock price and volume
• Why Establishment Labs Holdings Inc’s stock price changed recently
• Upgrades and downgrades for ESTA from analysts
• ESTA’s stock price momentum as measured by its relative strength

About Establishment Labs Holdings Inc (ESTA)

Before we jump into Establishment Labs Holdings Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.

Want to learn more about Establishment Labs Holdings Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Establishment Labs Holdings Inc.

What Caused Establishment Labs Holdings Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 30, 2024, there were 6 analysts who downgraded Establishment Labs Holdings Inc’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Establishment Labs Holdings Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Establishment Labs Holdings Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Establishment Labs Holdings Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Establishment Labs Holdings Inc (ESTA) by visiting AAII Stock Evaluator.

Relative Price Strength of Establishment Labs Holdings Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of August 30, 2024, Establishment Labs Holdings Inc has a weighted four-quarter relative price strength of -4.36%, which translates to a Momentum Score of 48 and is considered to be Average.

Want to learn more about how Establishment Labs Holdings Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Establishment Labs Holdings Inc Stock Price: Bottom Line

As of September 3, 2024, Establishment Labs Holdings Inc’s stock price is $42.20, which is down 7.9% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Establishment Labs Holdings Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.